Politico: High cost of healthcare travels over party lines

As the country's strong partisan divides become more apparent with an approaching midterm election, struggles related to the cost and accessibility of healthcare services are one top issue that both Republicans and Democrats currently agree on.

However, healthcare is such a contentious issue that it is playing a major role in the upcoming November elections, particularly in U.S. regions that are vulnerable to swing back and forth between blue and red, such as Pennsylvania, Politico reported. Recent polls have also underscored that healthcare is a top issue for voters.

Protections for those with pre-existing conditions are important for people on both sides of the aisle, and many Americans are planning to vote for whom they believe can fix healthcare and its rising costs.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.